October 18, 2017 6:02 AM ET


Company Overview of DNAVEC Corporation

Key Executives for DNAVEC Corporation

NameBoard RelationshipsTitleAge
Mamoru Hasegawa Ph.D.7 RelationshipsChief Executive Officer, President and Director--
Tsugumine Shu 15 RelationshipsManaging Director, General Manager of Business & Technology Development Division and Director--
Akihiro Iida 7 RelationshipsGeneral Manager of Business Department - Europe & US and Director--
Makoto Inoue 7 RelationshipsGeneral Manager of Science & Technology Development Department and Director--
Yohei Tanida 15 RelationshipsGeneral Manager of Corporate Management and Director56

DNAVEC Corporation Board Members*

NameBoard RelationshipsPrimary CompanyAge
Mamoru Hasegawa Ph.D. 7 RelationshipsDNAVEC Corporation--
Tsugumine Shu 15 RelationshipsDNAVEC Corporation--
Yohei Tanida 15 RelationshipsDNAVEC Corporation56
Akihiro Iida 7 RelationshipsDNAVEC Corporation--
Makoto Inoue 7 RelationshipsDNAVEC Corporation--
View All Board Members

DNAVEC Corporation Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation
Total Value of Options
Compensation as of Fiscal Year
DNAVEC Corporation CEO Compensation
Industry Average


Silicon Therapeutics Appoints Dr. Christopher Winter as Chief of R&D
October 16, 2017 4:30 PM ET
Boston Biomedical, Inc. Appoints Edgar Braendle, M.D., Ph.D., as Head of Research and Development and Chief Medical Officer
October 16, 2017 3:50 PM ET
Azurrx Biopharma, Inc. Announces Appointment of Vern Lee Schramm to the Board of Directors
October 16, 2017 12:30 PM ET
INmune Bio, Inc. Appoints Edgardo Baracchini to the Board of Directors
October 16, 2017 12:30 PM ET
Silence Therapeutics plc Appoints Annalisa Jenkins as Non-Executive Chair of Board of Directors
October 16, 2017 6:00 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact DNAVEC Corporation, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.